The global laparoscopic power morcellators market size is expected to reach USD 189.4 million by 2028 according to a new study by Polaris Market Research. The report “Laparoscopic Power Morcellators Market Share, Size, Trends, Industry Analysis Report, By Application (Hysterectomy, Myomectomy, Others); By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing preference for minimally invasive procedures and technological advancement in laparoscopic procedures will be the main reason for the industry growth. Increasing uterine fibroids and endometriosis cases lead to an increase in procedures such as myomectomy and hysterectomy, thereby boosting the power morcellators industry growth.
Uterine fibroids are non-cancerous growth in women’s uterus in their reproductive age, and the incidence is about 20 to 25% across the globe. Hysterectomy procedures are a standard treatment method for removing fibroids. It is also used in the treatment of early-stage uterine cancer. Globally uterine cancer or endometrial cancer affected 382,069 people and resulted in 89,929 deaths in 2018.
These products are Class II medical devices used during minimally invasive surgeries. The FDA has recently provided guidelines under which it can be used to treat hysterectomy or myomectomy with an appropriate tissue containment system in selected patient groups. The product is associated with various problems such as spreading malignancy, endometriosis, and direct visceral injury to the uterine and bladder.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/laparoscopic-power-morcellators-market/request-for-sample
Considering all these factors, the FDA has not recommended the use of laparoscopic power morcellators to remove uterine malignancy. Researchers are continuously studying the safety and efficacy of tissue containment systems, which will help better understand the use of the products in various surgical procedures in the coming years.
The emergence of COVID-19 is expected to hinder the growth of the global power morcellators industry during the forecast period as many laparoscopic procedures are canceled during pandemic times, owing to patient safety and a lack of healthcare infrastructure. Most laparoscopic surgeries are elective surgeries that are deemed as non-critical surgical procedures.
Market participants include Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), LiNA Medical, Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation are some of the key players operating in the global power morcellators market.
Polaris Market Research has segmented the laparoscopic power morcellators market report on the basis of application and region:
Laparoscopic Power Morcellators, Application Outlook (Revenue – USD Million, 2016 – 2028)
Laparoscopic Power Morcellators, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa